This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Hypercholesterolemia, Dyslipidemias, Hyperlipidemias, Lipid Metabolism Disorders or Metabolic Diseases
and you are
over 18
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

This Phase 1 study has been designed to evaluate the absolute bioavailability of PF-04950615 (RN316) in subjects with hypercholesterolemia who are not currently on lipid-lowering therapy.

Provided treatments

  • Biological: PF-04950615 (RN316)
  • Biological: PF-04950615 (RN316)
  • Biological: PF-04950615 (RN316)
  • Biological: PF-04950615 (RN316)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01435382. The sponsor of the trial is Pfizer and it is looking for 49 volunteers for the current phase.
Official trial title:
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Study To Assess The Pharmacokinetics And Pharmacodynamics Of Pf-04950615 Following Subcutaneous And Intravenous Doses In Adult Subjects With Hypercholesterolemia